Earnings Estimate

Search documents
Analysts Estimate Chemed (CHE) to Report a Decline in Earnings: What to Look Out for
ZACKS· 2025-07-22 15:00
Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Chemed despite higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Chemed is expected to report quarterly earnings of $4.76 per share, reflecting a 13% decrease year-over-year, while revenues are projected to be $619.83 million, a 4% increase from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 9.39% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate matches the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, suggesting no recent differing analyst views [12]. Historical Performance - Chemed has beaten consensus EPS estimates in two out of the last four quarters, with a recent surprise of +0.54% when it reported earnings of $5.63 per share against an expectation of $5.6 [13][14]. Zacks Rank - The stock currently holds a Zacks Rank of 4, indicating a less favorable outlook for an earnings beat [12]. Conclusion - Chemed does not appear to be a strong candidate for an earnings beat, and investors should consider other factors before making investment decisions [17].
Gear Up for Lazard (LAZ) Q2 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-07-22 14:15
Core Insights - Wall Street analysts forecast that Lazard (LAZ) will report quarterly earnings of $0.38 per share, reflecting a year-over-year decline of 26.9%, with anticipated revenues of $688.5 million, showing a slight increase of 0.6% compared to the previous year [1] Earnings Estimates - Over the last 30 days, there has been a downward revision of 1.3% in the consensus EPS estimate for the quarter, indicating a collective reconsideration by covering analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3] Key Metrics Projections - Analysts project 'Adjusted net revenue - Asset Management' at $261.01 million, indicating a year-over-year decline of 1.6% [5] - The estimate for 'Adjusted net revenue - Financial Advisory' is $417.05 million, reflecting a year-over-year increase of 2.2% [5] - 'Adjusted net revenue - Corporate' is expected to reach $9.44 million, suggesting a significant year-over-year decline of 17.8% [5] Assets Under Management - 'Assets under management - Total Fixed Income' is estimated at $45.12 billion, down from $46.11 billion year-over-year [6] - 'Assets under management - Total Equity' is projected to be $182.45 billion, compared to $190.43 billion from the previous year [6] - The estimated 'Assets under management - End of Period' is $236.20 billion, down from $244.67 billion year-over-year, while 'Assets under management - End of Period - Other' is expected to reach $8.64 billion, up from $8.13 billion [7] Stock Performance - Lazard shares have increased by 16.4% in the past month, outperforming the Zacks S&P 500 composite, which rose by 5.9% [7] - With a Zacks Rank 3 (Hold), LAZ is expected to closely follow overall market performance in the near term [7]
Curious about Boyd (BYD) Q2 Performance? Explore Wall Street Estimates for Key Metrics
ZACKS· 2025-07-22 14:15
Core Viewpoint - Boyd Gaming (BYD) is expected to report quarterly earnings of $1.67 per share, a 5.7% increase year-over-year, with revenues projected at $980.29 million, reflecting a 1.3% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised downward by 2.3% over the past 30 days, indicating a reassessment by analysts [2]. - Prior revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3]. Revenue Projections - Analysts predict 'Revenues- Online' to be $139.48 million, a 7.4% increase from the year-ago quarter [5]. - 'Revenues by Segment- Downtown Las Vegas' is estimated at $56.10 million, a decrease of 2.8% year-over-year [5]. - 'Revenues by Segment- Midwest and South' is expected to reach $531.53 million, indicating a 1.9% increase [5]. - 'Revenues by Segment- Managed & Other' is projected at $34.94 million, a 5.6% increase from the prior year [6]. - 'Revenues by Segment- Las Vegas Locals' is estimated at $221.91 million, reflecting a 1.4% decrease year-over-year [6]. Adjusted EBITDAR Estimates - 'Adjusted EBITDAR- Online' is forecasted to be $18.72 million, up from $17.06 million in the same quarter last year [7]. - 'Adjusted EBITDAR- Managed & Other' is expected to reach $24.01 million, compared to $23.14 million a year ago [7]. - 'Adjusted EBITDAR- Downtown Las Vegas' is projected at $20.91 million, down from $22.02 million in the previous year [8]. - 'Adjusted EBITDAR- Midwest and South' is estimated at $195.56 million, slightly up from $195.46 million year-over-year [8]. - 'Adjusted EBITDAR- Las Vegas Locals' is expected to be $105.06 million, down from $109.25 million in the prior year [9]. Stock Performance - Boyd shares have increased by 7.2% over the past month, outperforming the Zacks S&P 500 composite, which rose by 5.9% [9].
Robust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings
ZACKS· 2025-07-22 12:45
Core Viewpoint - Edwards Lifesciences Corp. is set to report its second-quarter 2025 results on July 24, with expectations of revenue and earnings declines compared to the previous year [1][2]. Q2 Estimates - The Zacks Consensus Estimate for revenues is $1.49 billion, indicating an 8.9% decline from the prior year's figure [2]. - The estimate for net earnings is 62 cents per share, reflecting an 11.4% decrease from the year-ago reported figure [2]. Estimate Revision Trend - Earnings estimates have remained unchanged at 62 cents per share over the past 60 days, indicating stability in expectations ahead of the earnings announcement [3]. Factors at Play - The Transcatheter Aortic Valve Replacement (TAVR) segment is expected to perform well in the U.S. due to the SAPIEN 3 Ultra RESILIA platform, with a projected revenue of $1.09 billion, representing a 5.2% year-over-year increase [4][5]. - The TMTT segment is anticipated to show significant growth, with revenues estimated at $130.4 million, a 57.1% improvement from the previous year, driven by the PASCAL and EVOQUE systems [6][8]. Segment Performance - The Surgical Structural Heart segment is expected to report revenues of $263.1 million, suggesting a modest 6.2% rise from the year-ago quarter, supported by the global adoption of the RESILIA portfolio [10][11]. - The commercial launch of the EVOQUE tricuspid replacement system is likely to have progressed well, aided by Medicare coverage [7]. Earnings Whispers - Edwards has an Earnings ESP of 0.00%, indicating no advantage in beating estimates this quarter [12]. - The company currently holds a Zacks Rank of 2 (Buy), suggesting a favorable outlook compared to other stocks [13].
Otis Worldwide to Report Q2 Earnings: Here's What Investors Must Know
ZACKS· 2025-07-21 16:51
Core Viewpoint - Otis Worldwide Corporation (OTIS) is set to report its second-quarter 2025 results on July 23, with expectations of mixed performance in earnings and sales compared to the previous year [1][3]. Earnings Performance - In the last reported quarter, adjusted earnings exceeded the Zacks Consensus Estimate by 1.1%, while net sales fell short by 1.7% [1]. - Over the trailing four quarters, OTIS has surpassed earnings estimates in two instances and missed in two, with an average surprise of 0.2% [2]. Estimate Revisions - The Zacks Consensus Estimate for earnings per share (EPS) has increased to $1.02 from $1.01 over the past 30 days, reflecting a 3.8% decline from the year-ago adjusted EPS of $1.06 [3]. - The consensus for net sales is projected at $3.68 billion, indicating a 2.3% growth from the previous year's $3.6 billion [3]. Sales Insights - The Service segment, contributing 65.3% to first-quarter 2025 net sales, is expected to drive year-over-year growth due to increased demand for maintenance and modernization [4]. - The New Equipment segment, which accounted for 34.7% of first-quarter 2025 net sales, is anticipated to face challenges, particularly in China and parts of EMEA, leading to a projected decline in sales [5][8]. Segment Performance - For the second quarter, net sales in the Service segment are expected to rise by 4.7% to $2.28 billion, while New Equipment segment sales are predicted to decrease by 5.2% to $1.35 billion [6]. Margin Analysis - The bottom line is expected to decline due to inflationary pressures, particularly from higher labor and material costs in the Service segment, alongside lower volume in the New Equipment segment [7]. - Despite these challenges, favorable pricing and productivity improvements may partially mitigate the negative impacts on margins [7][8]. SG&A Expenses - Selling, general and administrative (SG&A) expenses are likely to increase due to annual wage hikes and higher restructuring costs, with expectations for SG&A as a percentage of net sales to rise by 50 basis points to 13% [10]. Earnings Prediction - The model predicts an earnings beat for OTIS, supported by a positive Earnings ESP of +0.39% and a Zacks Rank of 2 (Buy) [11][12].
Analysts Estimate Enterprise Financial Services (EFSC) to Report a Decline in Earnings: What to Look Out for
ZACKS· 2025-07-21 15:00
Enterprise Financial Services (EFSC) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on July 28, might help the stock move higher if these key numbers are better ...
Curious about Edwards Lifesciences (EW) Q2 Performance? Explore Wall Street Estimates for Key Metrics
ZACKS· 2025-07-21 14:21
Core Insights - Analysts forecast Edwards Lifesciences (EW) to report quarterly earnings of $0.62 per share, reflecting a year-over-year decline of 11.4% [1] - Expected revenues are projected at $1.49 billion, indicating a decrease of 8.9% compared to the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a collective reevaluation by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock price performance [3] Key Metrics Projections - Net Sales by Product Group for Transcatheter Mitral and Tricuspid Therapies is estimated at $129.87 million, a change of +56.5% from the year-ago quarter [5] - Net Sales by Product Group for Surgical Structural Heart is projected at $259.33 million, reflecting a decrease of -1.9% from the previous year [5] - Net Sales by Product Group for Transcatheter Aortic Valve Replacement is expected to be $1.10 billion, showing an increase of +5.7% year-over-year [6] - Net Sales in Europe are anticipated to reach $353.07 million, indicating a change of +5.2% from the prior-year quarter [6] Regional Sales Expectations - Net Sales Outside of the United States are projected at $621.76 million, reflecting a change of +9.3% from the year-ago quarter [7] - Net Sales in the United States are expected to be $865.54 million, indicating a change of +6% year-over-year [7] - Net Sales in Japan are forecasted to reach $105.11 million, showing an increase of +20.3% from the prior-year quarter [7] - Net Sales for the Rest of World are projected at $163.59 million, reflecting a change of +12% from the previous year [8] Stock Performance - Edwards Lifesciences shares have increased by +3.6% in the past month, compared to the Zacks S&P 500 composite's +5.4% [8] - With a Zacks Rank 2 (Buy), EW is expected to outperform the overall market performance in the near term [8]
Unlocking Q2 Potential of Otis Worldwide (OTIS): Exploring Wall Street Estimates for Key Metrics
ZACKS· 2025-07-21 14:21
Core Insights - Otis Worldwide (OTIS) is expected to report quarterly earnings of $1.02 per share, a decline of 3.8% year-over-year, with revenues projected at $3.68 billion, reflecting a 2.3% increase compared to the same period last year [1] - The consensus EPS estimate has been revised upward by 1.4% over the past 30 days, indicating a collective reassessment by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3] Financial Metrics - Analysts forecast 'Net Sales- Service' to reach $2.32 billion, indicating a year-over-year increase of 6.4% [5] - 'Net Sales- New Equipment' is projected to be $1.34 billion, suggesting a decline of 5.6% year-over-year [5] - The average prediction for 'Adjusted Operating Profit- New Equipment' is $78.03 million, down from $113.00 million reported in the same quarter last year [5] - 'Adjusted Operating Profit- Service' is expected to be $576.18 million, compared to $550.00 million from the previous year [6] Market Performance - Shares of Otis Worldwide have returned +5.7% over the past month, outperforming the Zacks S&P 500 composite's +5.4% change [6] - Otis Worldwide holds a Zacks Rank 2 (Buy), indicating expectations to outperform the overall market in the near future [6]
Countdown to Invesco (IVZ) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
ZACKS· 2025-07-21 14:21
Core Viewpoint - Analysts project that Invesco (IVZ) will report quarterly earnings of $0.40 per share, reflecting a 7% decline year over year, while revenues are expected to reach $1.11 billion, marking a 1.9% increase from the same quarter last year [1] Earnings Estimates - There has been a 12.7% upward revision in the consensus EPS estimate over the last 30 days, indicating a collective reassessment by covering analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions to the stock, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3] Revenue Projections - Analysts expect 'Operating revenues- Other revenues' to be $53.25 million, indicating a year-over-year increase of 12.8% [5] - The consensus for 'Operating revenues- Service and distribution fees' is $375.77 million, suggesting a 3.9% year-over-year change [5] - 'Operating revenues- Performance fees' are projected to be $8.99 million, reflecting a 3.3% increase from the prior-year quarter [5] Assets Under Management - 'Average AUM - Total' is expected to reach $1855.71 billion, compared to $1669.30 billion a year ago [6] - 'Assets Under Management - Total' is projected to be $1892.28 billion, up from $1715.80 billion in the previous year [6] Stock Performance - Invesco shares have increased by 34.5% in the past month, outperforming the Zacks S&P 500 composite, which rose by 5.4% [6] - With a Zacks Rank 1 (Strong Buy), Invesco is anticipated to outperform the overall market in the near future [6]
Curious about Tri Pointe (TPH) Q2 Performance? Explore Wall Street Estimates for Key Metrics
ZACKS· 2025-07-21 14:21
Core Viewpoint - Tri Pointe Homes (TPH) is expected to report a significant decline in quarterly earnings and revenues, indicating challenges in the homebuilding sector [1][4]. Financial Performance Estimates - Analysts predict TPH will post quarterly earnings of $0.66 per share, a decrease of 47.2% year-over-year [1]. - Revenue is forecasted at $790.57 million, reflecting a year-over-year decline of 30.2% [1]. - The consensus estimate for 'Total revenues- Homebuilding- Home sales revenue' is $790.56 million, also down 30.2% from the previous year [4]. - 'Total revenues- Financial Service' is expected to be $18.89 million, showing an increase of 11.3% year-over-year [4]. Key Operational Metrics - 'New homes delivered' is estimated at 1,154, down from 1,700 in the same quarter last year [5]. - 'Net new home orders' are projected at 1,316, compared to 1,651 in the previous year [5]. - 'Selling communities at end of period' is expected to remain at 153, unchanged from the same quarter last year [5]. Pricing and Backlog Insights - The 'Average sales price in backlog' is anticipated to reach $757.80, up from $743.00 in the same quarter last year [6]. - The 'Average sales price of homes delivered' is projected at $686.14, compared to $666.00 in the previous year [6]. - The estimated 'Backlog (estimated dollar value)' is $1.42 billion, down from $2.00 billion in the same quarter last year [7]. - 'Backlog (homes)' is expected to be 1,876, a decrease from 2,692 in the previous year [7]. Income Projections - 'Income before income taxes- Financial services' is forecasted at $5.76 million, down from $6.08 million in the same quarter last year [8]. - 'Income before income taxes- Homebuilding' is expected to be $74.45 million, significantly lower than $153.15 million reported in the previous year [8]. Market Performance - TPH shares have increased by 8.1% over the past month, outperforming the Zacks S&P 500 composite, which rose by 5.4% [8].